FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100668870> ?p ?o ?g. }

• W3100668870 abstract "Abstract The potential mechanism of myelodysplastic syndromes (MDS) progressing to acute myeloid leukemia (AML) remains poorly elucidated. It has been proved that epigenetic alterations play crucial roles in the pathogenesis of cancer progression including MDS. However, fewer studies explored the whole-genome methylation alterations during MDS progression. Reduced representation bisulfite sequencing was conducted in four paired MDS/secondary AML (MDS/sAML) patients and intended to explore the underlying methylation-associated epigenetic drivers in MDS progression. In four paired MDS/sAML patients, cases at sAML stage exhibited significantly increased methylation level as compared with the matched MDS stage. A total of 1090 differentially methylated fragments (DMFs) (441 hypermethylated and 649 hypomethylated) were identified involving in MDS pathogenesis, whereas 103 DMFs (96 hypermethylated and 7 hypomethylated) were involved in MDS progression. Targeted bisulfite sequencing further identified that aberrant GFRA1 , IRX1 , NPY , and ZNF300 methylation were frequent events in an additional group of de novo MDS and AML patients, of which only ZNF300 methylation was associated with ZNF300 expression. Subsequently, ZNF300 hypermethylation in larger cohorts of de novo MDS and AML patients was confirmed by real-time quantitative methylation-specific PCR. It was illustrated that ZNF300 methylation could act as a potential biomarker for the diagnosis and prognosis in MDS and AML patients. Functional experiments demonstrated the anti-proliferative and pro-apoptotic role of ZNF300 overexpression in MDS-derived AML cell-line SKM-1. Collectively, genome-wide DNA hypermethylation were frequent events during MDS progression. Among these changes, ZNF300 methylation, a regulator of ZNF300 expression, acted as an epigenetic driver in MDS progression. These findings provided a theoretical basis for the usage of demethylation drugs in MDS patients against disease progression." @default.
• W3100668870 created "2020-11-23" @default.
• W3100668870 creator A5002926270 @default.
• W3100668870 creator A5009147079 @default.
• W3100668870 creator A5014048532 @default.
• W3100668870 creator A5015150059 @default.
• W3100668870 creator A5020923032 @default.
• W3100668870 creator A5022501218 @default.
• W3100668870 creator A5031612641 @default.
• W3100668870 creator A5037332032 @default.
• W3100668870 creator A5055726321 @default.
• W3100668870 creator A5063486512 @default.
• W3100668870 creator A5084645019 @default.
• W3100668870 date "2020-11-20" @default.
• W3100668870 modified "2023-10-09" @default.
• W3100668870 title "Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes" @default.
• W3100668870 cites W1958987550 @default.
• W3100668870 cites W1974079495 @default.
• W3100668870 cites W1977361366 @default.
• W3100668870 cites W1982273978 @default.
• W3100668870 cites W1986449954 @default.
• W3100668870 cites W1993236149 @default.
• W3100668870 cites W2014907331 @default.
• W3100668870 cites W2016247404 @default.
• W3100668870 cites W2026134786 @default.
• W3100668870 cites W2027060031 @default.
• W3100668870 cites W2036263818 @default.
• W3100668870 cites W2041539966 @default.
• W3100668870 cites W2055327476 @default.
• W3100668870 cites W2084123458 @default.
• W3100668870 cites W2088633051 @default.
• W3100668870 cites W2103771397 @default.
• W3100668870 cites W2107398329 @default.
• W3100668870 cites W2125421957 @default.
• W3100668870 cites W2128541703 @default.
• W3100668870 cites W2132297600 @default.
• W3100668870 cites W2133276269 @default.
• W3100668870 cites W2139296757 @default.
• W3100668870 cites W2146862337 @default.
• W3100668870 cites W2229721418 @default.
• W3100668870 cites W2271442009 @default.
• W3100668870 cites W2301702458 @default.
• W3100668870 cites W2416383529 @default.
• W3100668870 cites W2463367156 @default.
• W3100668870 cites W2524202495 @default.
• W3100668870 cites W2558256221 @default.
• W3100668870 cites W2589294969 @default.
• W3100668870 cites W2608406409 @default.
• W3100668870 cites W2741085177 @default.
• W3100668870 cites W2755525936 @default.
• W3100668870 cites W2789999172 @default.
• W3100668870 cites W2802076431 @default.
• W3100668870 cites W2806281670 @default.
• W3100668870 cites W2815117480 @default.
• W3100668870 cites W2889240474 @default.
• W3100668870 cites W2901472288 @default.
• W3100668870 cites W2908960043 @default.
• W3100668870 cites W2913402023 @default.
• W3100668870 cites W2925929837 @default.
• W3100668870 cites W2964215094 @default.
• W3100668870 cites W4297726681 @default.
• W3100668870 doi "https://doi.org/10.1038/s41419-020-03213-2" @default.
• W3100668870 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7679421" @default.
• W3100668870 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33219204" @default.
• W3100668870 hasPublicationYear "2020" @default.
• W3100668870 type Work @default.
• W3100668870 sameAs 3100668870 @default.
• W3100668870 citedByCount "16" @default.
• W3100668870 countsByYear W31006688702021 @default.
• W3100668870 countsByYear W31006688702022 @default.
• W3100668870 countsByYear W31006688702023 @default.
• W3100668870 crossrefType "journal-article" @default.
• W3100668870 hasAuthorship W3100668870A5002926270 @default.
• W3100668870 hasAuthorship W3100668870A5009147079 @default.
• W3100668870 hasAuthorship W3100668870A5014048532 @default.
• W3100668870 hasAuthorship W3100668870A5015150059 @default.
• W3100668870 hasAuthorship W3100668870A5020923032 @default.
• W3100668870 hasAuthorship W3100668870A5022501218 @default.
• W3100668870 hasAuthorship W3100668870A5031612641 @default.
• W3100668870 hasAuthorship W3100668870A5037332032 @default.
• W3100668870 hasAuthorship W3100668870A5055726321 @default.
• W3100668870 hasAuthorship W3100668870A5063486512 @default.
• W3100668870 hasAuthorship W3100668870A5084645019 @default.
• W3100668870 hasBestOaLocation W31006688701 @default.
• W3100668870 hasConcept C104317684 @default.
• W3100668870 hasConcept C150194340 @default.
• W3100668870 hasConcept C189235521 @default.
• W3100668870 hasConcept C190727270 @default.
• W3100668870 hasConcept C203014093 @default.
• W3100668870 hasConcept C2778729363 @default.
• W3100668870 hasConcept C2780007613 @default.
• W3100668870 hasConcept C2780817109 @default.
• W3100668870 hasConcept C33288867 @default.
• W3100668870 hasConcept C41091548 @default.
• W3100668870 hasConcept C502942594 @default.
• W3100668870 hasConcept C54355233 @default.
• W3100668870 hasConcept C86803240 @default.
• W3100668870 hasConceptScore W3100668870C104317684 @default.
• W3100668870 hasConceptScore W3100668870C150194340 @default.
• W3100668870 hasConceptScore W3100668870C189235521 @default.

• next